HERITAGE INVESTORS MANAGEMENT CORP
Position in NBIX — Neurocrine Biosciences Inc
CIK 937589
BETHESDA, MD
Position in NBIX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,186,521
+$259,072 QoQ
Shares Held
7,040
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#379
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HERITAGE INVESTORS MANAGEMENT CORP holds $21,531,235 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
205,182 | $14,744,378 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
114,247 | $2,811,618 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
43,543 | $1,475,236 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,939 | $1,313,482 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,040 | $1,186,521 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,186,521 | 7,040 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $927,449 | 7,040 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $998,483 | 7,040 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $988,275 | 7,040 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $884,857 | 7,040 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $778,624 | 7,040 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $960,960 | 7,040 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $811,148 | 7,040 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $969,196 | 7,040 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $970,956 | 7,040 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $927,590 | 7,040 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $792,000 | 7,040 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $663,872 | 7,040 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $712,588 | 7,040 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $840,977 | 7,041 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $759,507 | 7,151 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $730,222 | 7,491 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $763,406 | 8,143 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $693,539 | 8,143 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $780,995 | 8,143 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $792,476 | 8,143 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $791,906 | 8,143 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $780,506 | 8,143 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $783,030 | 8,143 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $993,446 | 8,143 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $418,728 | 4,838 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||